Our lab studies microRNAs and angiosarcomas which are aggressive vascular sarcomas from blood and lymphatic endothelial cells.

We aim to:

1. Discover the genetic drivers and critical microRNAs involved in angiosarcoma development.
2. Identify the key mediators of angiosarcoma metastasis.
3. Design and evaluate precision therapeutics to benefit patients of this devastating and understudied disease.